3 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 3 of 3 clinical reviews.
A detailed comparison of how the FDA and EMA regulate amlodipine, covering approval history, label differences, post-market surveillance, and what each framework means for prescribers and patients.
A complete timeline of amlodipine's FDA approval, label updates, generic entry, and post-market safety data from 1987 NDA filing through 2026.
A review of amlodipine besylate prescribing-information changes discussed in the 2020 to 2026 window, what is confirmed against FDA sources, and what still needs primary-source verification.